Find clinical trials for Non-Small-Cell Lung Cancer in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Montréal, QC, CAN:
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Montreal, Canada and 46 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Montréal, Canada and 43 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Montréal, Quebec, Canada and 209 other locations
This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small...
Phase 3
Montreal, Quebec, Canada and 88 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Montreal, Quebec, Canada and 230 other locations
The purpose of this study is to evaluate efficacy and safety of osimertinib (tablet) in combination with Datopotamab Deruxtecan (i.v. infusion) compa...
Phase 3
Montreal, Quebec, Canada and 39 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Greenfield Park, Quebec, Canada and 252 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Greenfield Park, Quebec, Canada and 275 other locations
, early-stage non-small cell lung cancer....
Phase 2
Montreal, Quebec, Canada and 94 other locations
The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patient...
Phase 3
Montreal, Quebec, Canada and 127 other locations
Clinical trials
Research sites
Resources
Legal